ACE inhibitors for the treatment of myocardial ischemia?

Abstract

Apart from their established use in the treatment of hypertension and heart failure, ACE inhibitors have been suggested to exert anti-ischemic effects. This article reviews the mechanisms of systemic and intracardiac angiotensin formation, as well as its interaction with the bradykinin, the prostaglandin, and the sympathetic nervous system. While high doses of angiotensin can precipitate myocardial ischemia. experimental data on a potential beneficial effect of ACE inhibitors on ischemic myocardial blood flow and function are inconsistent and controversial. Pooling the few available clinical data, several ACE inhibitors may attenuate myocardial ischemia at rest and during exercise. However, a significant fraction of patients does not benefit or even deteriorates. Recent experimental studies suggest a beneficial role of ACE inhibitors in attenuating reperfusion arrhythmias and postinfarction left ventricular remodeling. Unless the mechanisms and determinants of potential anti-ischemic actions of ACE inhibitors can be better defined, their use for treatment of myocardial ischemia cannot be recommended at present.

• Authors: C Linder, G Heusch
• Journal: Cardiovascular drugs and therapy (Cardiovasc Drugs Ther) Vol. 4 Issue 5 Pg. 1375-84 (Oct 1990) ISSN: 0920-3206 [Print] United States
• PMID: 2278872 (Publication Type: Journal Article, Review)

Chemical References

• Angiotensin-Converting Enzyme Inhibitors
• Angiotensin II

Topics

• Angiotensin II (physiology)
• Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
• Animals
• Coronary Disease (drug therapy)
• Humans